Ovarian cancer

You have access
Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports
SHU SOEDA, TAKAFUMI WATANABE, NORIHITO KAMO, TETSU SATO, CHIKAKO OKABE, MAKIKO UEDA, YUTA ENDO, KOJIMA MANABU, SHINJI NOMURA, SHIGENORI FURUKAWA, HIDEKAZU NISHIGORI, TOSHIFUMI TAKAHASHI and KEIYA FUJIMORI

Anticancer Research September 2020, 40 (9) 5263-5270; DOI: https://doi.org/10.21873/anticanres.14530
You have access
Cytokine-induced Killer T Cells Enhance the Cytotoxicity Against Carboplatin-resistant Ovarian Cancer Cells
YUEH PAN, YA-HSU CHIU, SHAO-CHIH CHIU, DER-YANG CHO, LIANG-MING LEE, YU-CHING WEN, JACQUELINE WHANG-PENG, CHI-HAO HSIAO and PING-HSIAO SHIH

Anticancer Research July 2020, 40 (7) 3865-3872; DOI: https://doi.org/10.21873/anticanres.14376
You have access
Primary and Interval Debulking Surgery Provide Similar Survival and Platinum Sensitivity Outcomes in Advanced Ovarian Cancer: A Retrospective Study
OLIVER GLOVER, VIREN ASHER, ANISH BALI, SUMMI ABDUL, ANNA COLLINS and ANDREW PHILLIPS

Anticancer Research July 2020, 40 (7) 3925-3929; DOI: https://doi.org/10.21873/anticanres.14383
You have access
GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian Cancer
FRÉDÉRIC SELLE, PIERRE-ETIENNE HEUDEL, ANNE-CLAIRE HARDY-BESSARD, ASTRID POZET, JEROME MEUNIER, LAURENCE GLADIEFF, JEAN-PIERRE LOTZ, MAGALI PROVANSAL, PAULE AUGEREAU, DOMINIQUE BERTON, NATHALIE BONICHON-LAMICHHANE, HUBERT ORFEUVRE, PATRICIA PAUTIER, ELSA KALBACHER, YOUSEF TAZI and DOMINIQUE SPAETH

Anticancer Research July 2020, 40 (7) 3939-3945; DOI: https://doi.org/10.21873/anticanres.14385
You have access
Magnetic Resonance and Ultrasound Fusion Imaging to Characterise Ovarian Masses: A Feasibility Study
ADRIEN CRESTANI, CLAIRE THEODORE, JEAN-MARC LEVAILLANT, ISABELLE THOMASSIN-NAGGARA, DOUNIA SKALLI, GRÉGOIRE MIAIHLE, YOHANN DABI, BASSAM HADDAD and CYRIL TOUBOUL

Anticancer Research July 2020, 40 (7) 4115-4121; DOI: https://doi.org/10.21873/anticanres.14410
You have access
Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian Tumours
PAVEL VLASAK, JIRI BOUDA, JAN KOSTUN, DENIS BEREZOVSKIY, MICHAL ZIKAN, VIT WEINBERGER, ONDREJ ONDIC, ZDENEK RUSAVY, RADEK KUCERA, ONDREJ TOPOLCAN, ZDENEK NOVOTNY and JIRI PRESL

Anticancer Research June 2020, 40 (6) 3527-3534; DOI: https://doi.org/10.21873/anticanres.14341
You have access
Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Ovarian Cancer Cells In Vitro
TEA KUITTINEN, PÄIVI ROVIO, TIINA LUUKKAALA, MARITA LAURILA, SEIJA GRÉNMAN, ANNE KALLIONIEMI and JOHANNA MÄENPÄÄ

Anticancer Research June 2020, 40 (6) 3129-3138; DOI: https://doi.org/10.21873/anticanres.14294
You have access
Neoadjuvant Chemotherapy Reduces the Treatment-free Interval After First-line Treatment in Patients With Advanced Ovarian Cancer
ANNE WENG EKMANN-GADE, CLAUS KIM HOGDALL, SVEND AAGE ENGELHOLM and CARSTEN LINDBERG FAGO-OLSEN

Anticancer Research May 2020, 40 (5) 2765-2770; DOI: https://doi.org/10.21873/anticanres.14248
You have access
Oral dosing of Recombinant Methioninase Is Associated With a 70% Drop in PSA in a Patient With Bone-metastatic Prostate Cancer and 50% Reduction in Circulating Methionine in a High-stage Ovarian Cancer Patient
QINGHONG HAN, YUYING TAN and ROBERT M. HOFFMAN

Anticancer Research May 2020, 40 (5) 2813-2819; DOI: https://doi.org/10.21873/anticanres.14254
You have access
Cholecystectomy as Part of Cytoreductive Surgery for Advanced Ovarian Cancer: Perioperative Outcomes
CHRYSOULA G. LIAKOU, NIKOLAOS AKRIVOS, BHASKAR KUMAR, TIMOTHY J. DUNCAN, HILARY L. TURNBULL, JOAQUIN J. NIETO and NIKOLAOS BURBOS

Anticancer Research April 2020, 40 (4) 2331-2336; DOI: https://doi.org/10.21873/anticanres.14200

Main menu

User menu

Search

Ovarian cancer

Pages